Self-administration of an intravenous drug for treating and preventing hereditary angioedema (HAE) attacks is safe

0

Intravenous news: MedPage Today report “Self-administration of an intravenous drug for treating and preventing hereditary angioedema (HAE) attacks is safe and feasible, a researcher said here. A total of 13 HAE patients were trained to infuse themselves with a C1 inhibitor product, and most were able to use it without major incident, reported Ralph Shapiro, MD, of Midwest Immunology Clinic in Plymouth, Minn. Only one patient had a problem with the self-infusion in the form of a breakthrough attack that occurred because limb swelling interfered with placing the IV line properly, Shapiro indicated at a poster presentation at the American College of Allergy, Asthma, and Immunology annual meeting.”

Main page

Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.